Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
23.1M
-
Number of holders
-
35
-
Total 13F shares, excl. options
-
12.2M
-
Shares change
-
+12.2M
-
Total reported value, excl. options
-
$48M
-
Value change
-
+$48M
-
Number of buys
-
35
-
Price
-
$3.94
Significant Holders of Turnstone Biologics Corp. - Common Stock, par value $0.001 per share (TSBX) as of Q3 2023
35 filings reported holding TSBX - Turnstone Biologics Corp. - Common Stock, par value $0.001 per share as of Q3 2023.
Turnstone Biologics Corp. - Common Stock, par value $0.001 per share (TSBX) has 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.2M shares
of 23.1M outstanding shares and own 52.74% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (3.1M shares), FMR LLC (2.83M shares), PFM Health Sciences, LP (1.52M shares), Point72 Asset Management, L.P. (833K shares), EVENTIDE ASSET MANAGEMENT, LLC (708K shares), CITADEL ADVISORS LLC (687K shares), 72 Investment Holdings, LLC (550K shares), SECTORAL ASSET MANAGEMENT INC (518K shares), ExodusPoint Capital Management, LP (321K shares), and BlackRock Inc. (281K shares).
This table shows the top 35 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.